
Medical Cannabis in Europe | Market Size to hit US$ 6,458 Million by 2028
Medical cannabis, also known as medical marijuana, is derived from cannabis plants such as cannabis indica, sativa, and hybrid strains. It contains active ingredients like tetrahydrocannabinol (THC) and cannabidiol (CBD), which are used to treat various medical conditions. It is commonly available in various forms, such as oils, capsules, and edible products. It helps modulate the immune system, promote neuroplasticity, and improve vascular and digestive functioning. As a result, medical cannabis is gaining immense traction in treating chronic pain, anxiety, anorexia, muscle spasms, and nausea across Europe.
Request Free Sample Report: https://www.imarcgroup.com/europe-medical-cannabis-market/requestsample
Market Trends
The Europe medical cannabis market is primarily driven by the rising prevalence of chronic medical conditions such as cancer, arthritis, Alzheimer’s, and migraine. Moreover, the increasing consumption of medical cannabis through inhalation, smoking, oral administration, or topical application, as it provides instant relief to patients by numbing pain receptors, is positively influencing the market growth. Additionally, easy product availability through authorized dispensaries and healthcare centers due to the legalization of medical cannabis in Europe has catalyzed market growth. Other factors, including ongoing research and development (R&D) activities to optimize the use of cannabinoids, surging adoption of medical cannabis for pain management, and significant improvements in healthcare infrastructure, are also anticipated to drive the market further.
Ask Analyst and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=3059&flag=C
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
The report has segmented the market on the basis of species, derivative, application, end use, route of administration and country.
Breakup by Species:
Indica
Sativa
Hybrid
Breakup by Derivative:
Cannabidiol (CBD)
Tetrahydrocannabinol (THC)
Others
Breakup by Application:
Cancer
Arthritis
Migraine
Epilepsy
Others
Breakup by End Use:
Pharmaceutical Industry
Research and Development Centres
Others
Breakup by Route of Administration:
Oral Solutions and Capsules
Smoking
Vaporizers
Topicals
Others
Breakup by Country:
Germany
France
United Kingdom
Italy
Spain
Others
Key highlights of the report:
Market Performance (2017-2022)
Market Outlook (2023- 2028)
Porter’s Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Related Reports by IMARC Group:
https://www.einpresswire.com/article/601150448/durable-medical-equipment-market-size-trends-industry-growth-and-outlook-2022-27
https://www.einpresswire.com/article/601151496/organ-preservation-market-growth-share-size-industry-trends-and-outlook-2022-27
https://www.einpresswire.com/article/601345983/human-insulin-market-to-grow-at-a-cagr-of-8-6-during-2022-2027-trends-size-share-report
https://www.einpresswire.com/article/616678146/sports-medicine-market-expected-to-reach-us-8-5-billion-by-2028-industry-cagr-of-5-77
https://www.einpresswire.com/article/616678524/ambulance-services-market-expected-to-reach-us-81-9-billion-by-2028-industry-cagr-of-8-89
https://www.einpresswire.com/article/616678756/artificial-organs-market-expected-to-reach-us-31-2-billion-by-2028-industry-cagr-of-8-5
https://www.einpresswire.com/article/616678951/feminine-hygiene-products-market-expected-to-reach-us-35-5-billion-by-2028-industry-cagr-of-4-93
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Elena Anderson
IMARC Services Private Limited
+1 6317911145
email us here

Distribution channels: Healthcare & Pharmaceuticals Industry
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Submit your press release